The TriMix Technology
Boosting immune response through the dendritic cell pathway in a targeted, safer and sustainable way eTheRNA’s TriMix contains three naked mRNA molecules: caTLR4 (that activates the immune sy...
eTheRNA
eTheRNA immunotherapies is a clinical-stage Belgian biotech company applying mRNA based immunotherapies to the treatment of cancer and infectious diseases. eTheRNA’s goal is to commercialize these immunotherapies to deliver long lasting clinical remission to cancer patients.
eTheRNA immunotherapies is a clinical-stage Belgian biotech company applying mRNA based immunotherapies to the treatment of cancer and infectious diseases. eTheRNA’s goal is to commercialize these immunotherapies to deliver long lasting clinical remission to cancer patients.